⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KRMD News
KORU Medical Systems, Inc. Common Stock (DE)
Form 8-K
sec.gov
KRMD
KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51 st Annual Oncology Nursing Society Congress
businesswire.com
KRMD
KORU Medical Systems Announces First Quarter 2026 Results
businesswire.com
KRMD
Form 8-K
sec.gov
KRMD
Form 8-K
sec.gov
KRMD
Form 8-K
sec.gov
KRMD
Form 8-K
sec.gov
KRMD
KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance
businesswire.com
KRMD
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System
businesswire.com
KRMD
KORU Medical Systems Announces 510(k) Submission for Clearance of the FreedomEDGE® System with a Commercialized Oncology Biologic
businesswire.com
KRMD